Det tilrådes, at den anbefalede dosis ikke overskrides i betragtning af den potentielle risiko for akromegali, hyperglykæmi og glukosuri.
It is advisable not to exceed the recommended dosage in view of the potential risks of acromegaly, hyperglycaemia, and glucosuria.